Description
Developer of drugs intended to treat viral diseases. The company's drugs are discovered to treat viral diseases using structure action relationships (SAR) that inhibit virus-host interactions required for egress and spread of infectious virus from the cell, enabling doctors to treat diseases caused by filoviruses (Ebola and Marburg), arenaviruses (Lassa Fever and Junín), influenza A virus and rhabdoviruses (rabies).
Contact Information
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
1. Accelerator/Incubator | 01-Aug-2015 | Completed | Startup |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Mike Saporito | Chief Executive Officer & President |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
UPstart (Philadelphia) | Accelerator/Incubator | 000 0000 | 000000 0 |